Professional Documents
Culture Documents
MEDICAL RESEARCH
YL 1 | AY 2021 – 2022 FINALS
1
COVERAGE (Arial, 11, Centered) SOURCES
Long Exam 1 Part 1
I. Orientation/Overview of Research Designs Long Exam 1 Part 2
II. Scientific Misconducts: Plagiarism
III. Acquiring ideas in research
IV. Outline of a Research protocol
V. AMA Citation of Journals
VI. Introduction of Evidence-based Medicine
DISCLAIMER: The contents of this samplex are not guaranteed to be on the examinations. This only serves for supplemental learning only.
Please read your notes before using. USE AT YOUR OWN DISCRETION.
[MDR] Page 1 of
15
FINALS SAMPLEX RATIONALE
3. It is the year 2022 and roughly 40% of the world’s population has D
been vaccinated against COVID19. The majority of the applicants for
emergency use authorization of the COVID19 vaccine have been
accepted. Vaccine Pf showed to have been at least 95% efficacious
in terms of preventing COVID19 infection while Vaccine Novax
showed at least 96% efficacy on Phase III clinical trials. Efficacy is
also known as Relative Risk Reduction. A study was done to
compare these two vaccines in terms of preventing COVID19
infection. It is a landmark study where it will recruit at least 500,000
subjects around the globe. Scientists wanted to determine whether
they are comparable with at most 1% difference in terms of efficacy.
This study will most likely run for at least six months. Which of the
following statements shall be appropriate for the particular scenario?
[MDR] Page 2 of
15
FINALS SAMPLEX RATIONALE
6. An investigational drug was subjected to a clinical trial to A Phase I trial: tests a NEW drug in a small group of subjects for the
determine its efficacy in lowering blood pressure among subjects FIRST time to evaluate SAFE DOSAGE, and identify SIDE EFFECTS
with primary hypertension. The study took place in multiple centers
spanning several continents globally. The study was able to recruit Phase II trial: Drug is given to a larger group to see whether it is
over a million participants. The results have shown that the drug is effective and further evaluate SAFETY.
efficacious. The drug was then approved for medical use. Which
phase of a clinical trial determines the appropriate dosage of this Phase III: Large groups to confirm EFFECTIVENESS, monitor SIDE
investigational drug? EFFECTS, do compare with current treatments.
[MDR] Page 4 of
15
FINALS SAMPLEX RATIONALE
a)
The inclusion criteria is a possible source of bias, therefore
the needs careful planning
b) Whenever, appropriate students have to include journals
written in different languages
c) A funnel-plot is needed to determine publication bias
d) The students should take into account whether intention-to-
treat analysis was done in each studies they review
&
e) All of the choices are appropriate
11. According to a study by L. Korn and N. Davidovitch in 2016 D A study was done by L. Korn and N. Davidovitch in 2016 entitled: “The
entitled “The Profile of Academic Offenders: Features of Students Profile of Academic Offenders: Features of Students Who Admit to
Who admit to Academic Dishonesty, which of the following choices Academic Dishonesty”
is/are considered appropriate.
Objective: To characterize students who report academic dishonesty
a)
All of the choices are considered correct
b)
Academic dishonesty is higher among those with low Conclusion: There is a higher risk or prevalence of academic dishonesty
perceived fitness than with higher perceived fitness. in participants (students) who have more:
c) There were more males in the study as compared to → negative perceptions on academics
females. → negative study experience
→ negative personal perceptions
O
d) There is no significant differences in academic dishonesty
→ more involved in deviant behaviors
whether the the student is experiencing high level of stress
as compared with low levels of stress
Trans 1.04 p.1
[MDR] Page 5 of
15
FINALS SAMPLEX RATIONALE
12. According to PM Kumar and NS Priya, to avoid plagiarism, it is A Tips to avoid plagiarism:
important to have adequate time to finish the protocol, have a clear 1. Have adequate amount of time to finish the article
understanding of the concept, avoid writing several papers of similar 2. Have a clear understanding of the concept
types, and always cite the not-so-common language. 3. Write new ideas using own words
4. Use few appropriate and accurate sources
8
a) True 5. Avoid patchwork
6. Always cite not common language (if the words/terms are not
b) False
L
common)
7. Don’t copy/paste articles to your manuscript
8. Cite accurately
9. Always credit the original sources
10. Avoid writing several papers of the same type and submitting to
different journals at any one time
11. Consult a proof reader to finalize the manuscript
12. Use anti-plagiarism tools
13. Follow author’s guidelines
Trans 1.04 p.2
13. Regarding the abstract, the following is the sequence of the B
standard structure of the abstract. It usually begins with the
objectives followed by the study design which includes the
participants and interventions. Next in the list is the conclusion which
is usually followed by the data analysis and the study outcome
measure.
a) True
⑧
b) False
15. Before conducting a research study, it is a requirement that the B “The medical research protocol should be approved by the Ethics and
Ethics Review Board or (IRB) of your institution has approved your Review Board of an institution… The board may initially approve the
research protocol. In addition, once approved, there is no need for protocol and periodically monitor/review the research.”
Trans 1.02.1 p.4
[MDR] Page 6 of
15
FINALS SAMPLEX RATIONALE
a) True
b) False
0
16. When citing a journal article in AMA format, the following is/are A → Volume number (no period)
considered appropriate. → Issue number in brackets ()
Trans 1.02.1 Appendix
0
a)
b)
The Volume number is followed brackets
All of the choices are appropriate
c) The title of the research is placed under italics
d) The year of publication ends with a coma
e) The first name of the author ends with a period
17. This is the very first critical step in a research process and forms C Research Question – very first critical step in research process and
the backbone of research. forms the backbone of a good research
[MDR] Page 7 of
15
FINALS SAMPLEX RATIONALE
19. This is a characteristic of a research question where the PICOM E Check #18 rationale.
must consist of intellectual and of academic value. In addition, the
clinical question has to be based on the current scenario.
a) Feasible
b) Interesting
c) Ethical
d) Novel
0
e) Relevance
20. Your friend is asking you about a clinical question. It is about the C CAUSALITY – COMPARATIVE – aims to research for the effect of 2 or
treatment of bronchial asthma. The clinical question is: “Among more rival treatments
Filipinos aged 18-59, what is the -
effectiveness of using Salmeterol
metered-dose inhaler versus Vilanterol Inhaler, in the management RELATIONSHIP – evaluates relation between variables
of mild to moderate bronchial asthma using an open- labeled,
parallel, superiority, randomized clinical trial. What type of clinical COMPOSITION – involves breakdown of a whole into its components
question is this?
CAUSALITY – COMPARATIVE INTERACTIONS – most complex
a) Relationship question among other research questions /interaction between treatments)
b) Composition
c) Causality-comparative DESCRIPTIVE – COMPARATIVE – a question which the researcher
will ensure that all is the same within groups except the issue in
-
d)
e)
Causality-comparative Interaction
-
Descriptive-comparative
Y question
-
[MDR] Page 8 of
15
FINALS SAMPLEX RATIONALE
~
23. COVID19 cases are rising in the NCR. The probability of cases is B Cohort studies – use for common disease based on risk factors /exposure OF
rare risk
getting higher as the proportion of cases rises among the tested factors
population. According to experts, the rate of transmission has been Case Reports – no control/expiremental descriptive
; study of
rare condition
slowing down due to lockdown measures. You wanted to determine
whether the proportion of cases with the tested population shall rise Case Control Studies – use for rare disease (multiple case reports/ subjects)
or decline in the following weeks. What type of research design
would you most likely work on? Randomized Controlled Trial – strongest of all study designs; subjects
are allocated at random to receive interventions
a) Cross-sectional study
b)
O Cohort study Systematic Review – gathers evidences that fits a pre-specified eligibity
c) Case-control study criteria to answer a specific research question
d) Case report
e) Meta-analysis Meta Analysis – is a subject of systematic review and uses statistical
analyses
0
a) All of the above
b) Talk to your colleagues in the same field about it and ask
their opinion
c) Discuss the issue with the population in question
d) Try asking your consultant or research mentor for opinion
e) You can modify your question
attainable
c) Attainable R -
realistic
d) Measurable
T. time-bound
e) Specific
O
a) True
b) False
[MDR] Page 9 of
15
FINALS SAMPLEX RATIONALE
28. A group of researchers is working on a study to determine the D Check #23 rationale.
side effects of ivermectin. This medication has been an issue during
the pandemic as there is a lack of robust evidence for its use on
COVID19 infection. What type of research is the best type of study to
determine the side effects of a medication?
rare case
descriptive
a)
b)
Case reports -
Case Control studies
-comparison
2
of
subjects basedres a
30. Your friend is asking you for help with a journal topic. It is about A
the management of a surgical procedure where Procedure A was
compared to the Standard Procedure. The study recruited X number
of participants with a surgical condition. The endpoint is the
resolution of the disease. You found out that those who underwent
Procedure A have a 93% success rate while the standard treatment
has a success rate of 89%. The relative risk is 0.63 (p = 0.06). From
this data, what can you tell your friend about the journal?
0
a) Procedure A is comparable to standard procedure
[MDR] Page 10 of
15
FINALS SAMPLEX RATIONALE
a) Harm
O
b) Systematic review
c) Prognosis
d) Therapy
e) Diagnosis
predicting the
35. A study was conducted to determine the treatment effect of a a. Risk in Treatment = 0.30 a. Risk in Treatment = 0.30
new oral hypoglycemic agent (Drug A) for the management of
diabetes type II. It was compared with the standard drug, Metformin. b. Risk in Control = 0.40 Group 1
It is a double-blinded, parallel, randomized controlled trial. The end- = 700 in 1000 met end point
point of the study was to achieve an HbA1c score of 7 and below
within 3 months. The study recruited 1000 participants with diabetes
type 2. A baseline HBa1c test was done. The participants were
[MDR] Page 11 of
15
FINALS SAMPLEX RATIONALE
equally randomized to Group 1 (Drug A) (n=1000) and Group 2 c. Absolute Risk Reduction = 300 did not meet end point
(Metformin) (n=1000). They were followed up every month to monitor 0.10 =300/1000 = Risk in Treatment
for their Hba1c levels. Or 0.30
d. Relative Risk = 0.75
There were no drop-outs. At the end of the study, the results showed b. Risk in Control = 0.40
that 700 out of 1000 in Group 1 met the endpoint while 600 out of
1000 in Group 2 (Metformin) met the endpoint. Group 2 (Control)
= 600 / 1000 met end point
Compute for the following: (answer in 2 decimal points) 400 did not meet endpoint
=400/1000
1. Risk in treatment =0.40
2. Risk in control
3. Absolute risk reduction c. Absolute Risk Reduction = 0.10
4. Relative risk
5. Relative risk reduction Absolute Risk Reduction= Risk Control – Risk Treatment
= 0.40 – 0.30
= 0.10
36. A diagnostic study was done to determine the diagnostic A. Precision = 0.25 Imaging A
accuracy of an imaging study (Imaging A) to detect a certain disease. B. Accuracy= 0.30 ONLY 10 tested (+)
It was compared with a gold standard, the CT scan. The study ONLY DETECT 20 (-)
recruited 100 subjects. CT scan was able to detect 50 cases among Gold Standard CT
100 participants. Among those who tested positive for CT scan, only detect 50(+) out of 100
10 tested positive Imaging A. Also, among who tested negative for Detect 50 (-) out of 100
CT scan, only 20 tested negative with imaging A. (answer in 2
decimal points)
A. Compute for the precision of the test (Imaging A). B. compute for
the overall accuracy of Imaging A.
A. Precision:
B. Accuracy
37. Your patient is asking you whether treatment A is more beneficial NNT= 5 NNT = 1/ARR
than treatment B in the management of irritable bowel syndrome.
You found a journal on treatment comparing treatment A with Where NNT is = Number Needed to Treat
treatment B and the study recruited 20,000 participants. You found And ARR is = Absolute Risk Reduction
out that the risk in treatment A is 0.2 while the risk in treatment B is ARR = Risk control – Risk in treatment
0.4. In addition, the relative risk for this clinical trial is 2. You wanted = 0.4 – 0.2
to compute the benefits of the treatment for your patient by = 0.2
determining the number needed to treat. Compute for the number So, NNT = 1 / 0.2
needed to treat. (*Answer in WHOLE NUMBER only). NNT = 5
38. A diagnostic test was done to determine the diagnostic accuracy A. Sensitivity
of test A in diagnosing tuberculosis. =0.50
This was compared with the gold standard, a blood culture. The B. Specificity
study was able to recruit 1000 participants. The result showed that =0.25
200 of the whole population turned out to be positive with the blood C. Positive Likelihood ratio
culture while 800 of them tested negative. =0.67
D. Negative Likelihood ratio
Among those who tested positive with blood culture, 100 of them =2
tested positive with test A. E. Accuracy of Test A
Also, among those who tested with negative blood culture, 200 of =0.30
them tested negative with test A. With the above data, compute for
(answer in nearest 2 decimal points) the following:
A. Sensitivity
B. Specificity
C. Positive Likelihood ratio
D. Negative Likelihood ratio
E. Accuracy of Test A A. Sensitivity
Formula = A / (A+C)
Where, A = With Disease and Positive Test
C = With Disease and Negative Test
Formula = D / (B+D)
Where, B = No Disease and Positive Test
D = No Disease and Negative Test
=100/200
=0.50
[MDR] Page 13 of
15
FINALS SAMPLEX RATIONALE
B. Specificity
=200/800
=0.25
E. Accuracy of Test A
= (100+200) / (100+200+600+100)
= 300 / 1000
= 0.30
39. retention among call center agents who drink at least 1 cup of Risk in Treatment (Rt)
coffee per night shift. The goal was to determine whether those who =0.5
drink coffee have a higher than standard memory retention during
their shifts. Risk in Control (Rc)
=0.1 Rt = 50/100
Rt= 0.5
They were compared with a control group and are matched
according to age, sex, weight, educational attainment, and job Relative Risk (RR)
position. It is to minimize the possible confounders. The study =5.0
recruited 100 call center agents who regularly drink coffee (Group A) Rc= 10/100
in their shifts and the additional 100 matched controls (Group B). Rc= 0.1
[MDR] Page 14 of
15
FINALS SAMPLEX RATIONALE
RR= Rt/Rc
RR= 0.5/0.1
RR= 5.0
APPENDIX
[MDR] Page 15 of
15